Nonosseous, Nonurologic Uptake on Bone Scintigraphy: Atlas and Analysis

Seminars in Nuclear Medicine

Volumn 40, Issue 4, 2010, Pages 242-256

  Zuckier, Lionel S ^a   Freeman, Leonard M ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODOHIPPURATE SODIUM I 131; TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT;

ARTIFACT; BONE DEMINERALIZATION; BONE METASTASIS; BONE SCINTISCANNING; BRAIN INFARCTION; BREAST CANCER; BREAST CARCINOMA; CALCIFICATION; CALCINOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST MEDIUM EXTRAVASATION; DEEP VEIN THROMBOSIS; DRUG HALF LIFE; DRUG UPTAKE; HEART INFARCTION; HUMAN; HYPERPARATHYROIDISM; LEG PAIN; METASTASIS POTENTIAL; PLEURA EFFUSION; REVIEW; BLADDER; BONE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONNECTIVE TISSUE; DIAGNOSTIC USE; METABOLISM; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION;

ARTIFACTS; BONE AND BONES; CONNECTIVE TISSUE; HUMANS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; URINARY BLADDER;

EID: 77952692611     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.02.003     Document Type: Review

References (91)

1. Scharf S. SPECT/CT imaging in general orthopedic practice. Semin Nucl Med 39 (2009) 293-307
2. Beheshti M., Langsteger W., and Fogelman I. Prostate cancer: Role of SPECT and PET in imaging bone metastases. Semin Nucl Med 39 (2009) 396-407
3. Ben-Haim S., and Israel O. Breast cancer: Role of SPECT and PET in imaging bone metastases. Semin Nucl Med 39 (2009) 408-415
4. Chua S., Gnanasegaran G., and Cook G.J. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): Role of SPECT and PET in imaging bone metastases. Semin Nucl Med 39 (2009) 416-430
5. Leffers D., and Collins L. An overview of the use of bone scintigraphy in sports medicine. Sports Med Arthrosc 17 (2009) 21-24
6. Van Der Bruggen W., Bleeker-Rovers C.P., Boerman O.C., et al. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: A systematic review. Semin Nucl Med 40 (2010) 3-15
7. Vieras F., and Boyd C.M. Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J Nucl Med 16 (1975) 1109-1114
8. Gentili A., Miron S.D., Adler L.P., et al. Incidental detection of urinary tract abnormalities with skeletal scintigraphy. Radiographics 11 (1991) 571-579
9. Maher F.T. Evaluation of renal and urinary tract abnormalities noted on scintiscans: A retrospective study of 1,711 radioisotope skeletal surveys performed in an 18-month period. Mayo Clin Proc 50 (1975) 370-378
10. Peller P.J., Ho V.B., and Kransdorf M.J. Extraosseous Tc-99m MDP uptake: A pathophysiologic approach. Radiographics 13 (1993) 715-734
11. Gentili A., Miron S.D., and Bellon E.M. Nonosseous accumulation of bone-seeking radiopharmaceuticals. Radiographics 10 (1990) 871-881
12. Loutfi I., Collier B.D., and Mohammed A.M. Nonosseous abnormalities on bone scans. J Nucl Med Technol 31 (2003) 149-153 quiz:154-146
13. Gnanasegaran G., Cook G., Adamson K., et al. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med 39 (2009) 380-395
14. Kaye J., and Hayward M. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: Pictorial review. Australas Radiol 46 (2002) 13-21
15. In: Yun R.U., Alvai A., Collier B.D., et al. (Eds). Atlas of Nuclear Medicine Artifacts and Variants (ed 2) (1990), Year Book Medical Publishers, Chicago, IL
16. Silberstein E., Mcafee J., and Spasoff A. Diagnostic Patterns in Nuclear Medicine (1998), Society of Nuclear Medicine, Reston, VA
17. In: Datz F. (Ed). Gamuts in Nuclear Medicine (ed 3) (1995), Mosby, St. Louis, MO
18. In: Citrin D., and Mckillop J. (Eds). Atlas of Technetium Bone Scans (1978), W. B. Saunders (WB) Co Ltd, Philadelphia, PA
19. Heck L.L. Extra-osseous localization of phosphate bone agents. Semin Nucl Med 10 (1980) 311-313
20. Chaudhuri T.K. Bone imaging-Tracer uptake in non-neoplastic osseous and nonosseous disease processes. Semin Nucl Med 13 (1983) 78-81
21. Lin D.S. Left upper quadrant increased uptake in bone imaging. Semin Nucl Med 13 (1983) 179-180
22. Ackerman L., Elam E., Bushnell D., et al. Bowel visualization in bone scintigraphy. Semin Nucl Med 17 (1987) 81-82
23. Shukla L.W., Lin D.S., and Kutka N. Splenic uptake in bone imaging. Semin Nucl Med 18 (1988) 71-73
24. Goldfarb C.R., Ongseng F., Kuhn M., et al. Non-skeletal accumulation of bone seeking agents: Pelvis. Semin Nucl Med 18 (1988) 159-161
25. Lin D.S. Uniappendicular increased uptake in bone imaging. Semin Nucl Med 18 (1988) 165-166
26. Lin D.S. Increased uptake in the lower neck on bone images. Semin Nucl Med 18 (1988) 167-168
27. Ibis E., Krasnow Z.A., Isitman A.T., et al. Liver uptake of technetium-99m-labeled phosphate compounds: An updated gamut, 1992. Semin Nucl Med 22 (1992) 202-205
28. Hung G.U., Tsai S.C., Kao C.H., et al. Incidental finding of pancreatic calcification on bone scan. Semin Nucl Med 30 (2000) 231-233
29. Tsai S.C., Kao C.H., Lin W.Y., et al. Unusual intestinal and urinary tract accumulation on bone scan: A case with Indiana pouch. Semin Nucl Med 30 (2000) 310-312
30. Tuncel M., Erbas B., and Mahmoudian B. Gamut: Soft tissue uptake of bone radiopharmaceuticals. Semin Nucl Med 33 (2003) 334-337
31. Harwood S.J., Wang T.Y., Camblin J.G., et al. Intense focal uptake of technetium-99m diphosphonate in a soft tissue mass. Semin Nucl Med 21 (1991) 335-338
32. Pacheco E.M., Civelek A.C., Natarajan T.K., et al. Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants. A primate model. Arch Ophthalmol 115 (1997) 1173-1177
33. Thrall J.H., Ghaed N., Geslien G.E., et al. Pitfalls in Tc99m polyphosphate skeletal imaging. Am J Roentgenol Radium Ther Nucl Med 121 (1974) 739-747
34. Kawase T., Fujii H., Nakahara T., et al. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer. Clin Nucl Med 34 (2009) 173-174
35. Coolens J.L., Devos P., and De Roo M. Diffuse pulmonary uptake of 99mTc bone-imaging agents: Case report and survey. Eur J Nucl Med 11 (1985) 36-42
36. Chaudhuri T.K. Liver uptake of 99mTc-diphosphonate. Radiology 119 (1976) 485-486
37. Zimmer A.M., and Pavel D.G. Experimental investigations of the possible cause of liver appearance during bone scanning. Radiology 126 (1978) 813-816
38. Subramanian G., and Mcafee J.G. A new complex of 99mTc for skeletal imaging. Radiology 99 (1971) 192-196
39. Bull U., Pfeifer J.P., Niendorf H.P., et al. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging. Br J Radiol 50 (1977) 629-636
40. Davis M.A., and Jones A.L. Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging. Semin Nucl Med 6 (1976) 19-31
41. Galasko C.S. Mechanism of uptake of bone imaging isotopes by skeletal metastases. Clin Nucl Med 5 (1980) 565-568
42. In: Saha G. (Ed). Fundamentals of Nuclear Pharmacy (ed 5) (2004), Springer, New York, NY
43. Vallabhajosula S., and Owunwanne A. Pathophysiology and mechanisms of radiopharmaceutical localization. In: Elgazzar A. (Ed). The Pathophysiologic Basis of Nuclear Medicine (2006), Germany, Springer-Verlag Berlin Heidelberg, Berlin
44. In: Kumar V., Abbas A.K., Fausto N., et al. (Eds). Robbins and Cotran Pathologic Basis of Disease (ed 8) (2010), W.B. Saunders, Philadelphia, PA
45. Desai A., Eymontt M., Alavi A., et al. 99mTc-MDP uptake in nonosseous lesions. Radiology 135 (1980) 181-184
46. Silberstein E.B., and Delong S. Femoral artery calcification. Detection by bone scintigraphy. Clin Nucl Med 10 (1985) 738-739
47. Silberstein E.B., Clark R.A., and Delong S. Clinical and radiographic correlates of femoral artery visualization on bone scan. Int J Rad Appl Instrum B 16 (1989) 709-713
48. Corut A., Senyigit A., Ugur S.A., et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 79 (2006) 650-656
49. Tachibana T., Hagiwara K., and Johkoh T. Pulmonary alveolar microlithiasis: Review and management. Curr Opin Pulm Med 15 (2009) 486-490
50. Shah T.C., Talwar A., Shah R.D., et al. Pulmonary alveolar microlithiasis: Radiographic and scintigraphic correlation. Clin Nucl Med 32 (2007) 249-251
51. Meissner A., Mamoulakis C., de la Rosette J.J., et al. Clinical update on testicular microlithiasis. Curr Opin Urol 19 (2009) 615-618
52. In: Baker S., Cho K., and Stamford C. (Eds). The Abdominal Plain Film with Correlative Imaging (1998), Appleton & Lange, Stamford, CT
53. Lentle B.C., Percy J.S., Rigal W.M., et al. Localization of Tc-99m pyrophosphate in muscle after exercise. J Nucl Med 19 (1978) 223-224
54. Winter P.F. Letter: Splenic accumulation of 99mTc-diphosphonate. J Nucl Med 17 (1976) 850
55. Moallem A., and Lichsztral R. Deep vein thrombosis detection by 99m TC-MDP scanning. Angiology 35 (1984) 515-518
56. Zuckier L.S., Patel K.A., Wexler J.P., et al. The hot clot sign. A new finding in deep venous thrombosis on bone scintigraphy. Clin Nucl Med 15 (1990) 790-793
57. Karanauskas S., Starshak R.J., and Sty J.R. Heterotopic Tc-99m MDP uptake secondary to phlebitis. Clin Nucl Med 16 (1991) 329-331
58. Byun H.H., Rodman S.G., and Chung K.E. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J Nucl Med 17 (1976) 374-375
59. Van Antwerp J.D., Hall J.N., and O'Mara R.E. Soft-tissue concentration of Tc-99m phosphates associated with injections of iron dextran complex. J Nucl Med 18 (1977) 855
60. Hashimoto T., Koizumi K., Hanawa N., et al. Extraosseous skin and subcutaneous tissue uptake of Tc-99m HMDP in a surgical scar after laparotomy. Clin Nucl Med 28 (2003) 1000-1001
61. Brown M., Swift T.R., and Spies S.M. Radioisotope scanning in inflammatory muscle disease. Neurology 26 (1976) 517-520
62. Vanantwerp J.D., O'Mara R.E., Pitt M.J., et al. Technetium-99m-diphosphonate accumulation in amyloid. J Nucl Med 16 (1975) 238-240
63. Worsley D.F., and Lentle B.C. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. J Nucl Med 34 (1993) 1612-1615
64. Romyn A.M., Bushnell D.L., Freeman M.L., et al. Visualization of metastatic liver disease on technetium-99m bone scintigraphy. Clin Nucl Med 12 (1987) 264-267
65. Berg G.R., Kalisher L., Osmond J.D., et al. 99mTc-diphosphonate concentration in primary breast carcinoma. Radiology 109 (1973) 393-394
66. Mcdougall I.R., and Pistenma D.A. Concentration of 99mTc diphosphonate in breast tissue. Radiology 112 (1974) 655-657
67. Charkes N.D., and Makler Jr. P.T. Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: Concise communication. J Nucl Med 22 (1981) 601-605
68. Makler Jr. P.T., and Charkes N.D. Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging. J Nucl Med 21 (1980) 641-645
69. Sagar V.V., Piccone J.M., and Charkes N.D. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow. J Nucl Med 20 (1979) 1257-1261
70. Yu J.Q., Zhuang H., Posteraro A., et al. Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis. Clin Nucl Med 30 (2005) 742-743
71. Borzutzky C.A., Spinuzza T.J., and Turbiner E.H. Technetium-99m MDP accumulation in malignant ascites. Clin Nucl Med 10 (1985) 731-732
72. Lamki L., Cohen P., and Driedger A. Malignant pleural effusion and Tc-99m MDP accumulation. Clin Nucl Med 7 (1982) 331-333
73. Sandler E.D., Hattner R.S., Parisi M.T., et al. Clinical utility of bone scan features of pleural effusion: Sensitivity and specificity for malignancy based on pleural fluid cytopathology. J Nucl Med 35 (1994) 429-431
74. Siegel M.E., Walker W.J., and Campbell J.L. Accumulation of 99mTc diphosphonate in malignant pleural effusions: Detection and verification. J Nucl Med 16 (1975) 883-885
75. Cole T.J., Balseiro J., and Lippman H.R. Technetium-99m-methylene diphosphonate (MDP) uptake in a sympathetic effusion: An index of malignancy and a review of the literature. J Nucl Med 32 (1991) 325-327
76. Lee K.H., Chung J.K., Lee D.S., et al. Intestinal leakage of technetium-99m-MDP in primary intestinal lymphangiectasia. J Nucl Med 37 (1996) 639-641
77. Roach P.J., Itrato D., and Treves S.T. Bowel visualization on bone scan because of protein losing enteropathy. Clin Nucl Med 19 (1994) 1114-1116
78. Lee V.W., Leiter B.E., Weitzman F., et al. Occult gastric bleeding demonstrated by bone scan and Tc-99m-DTPA renal scan. Clin Nucl Med 6 (1981) 470-473
79. Sherkow L., Ryo U.Y., Fabich D., et al. Visualization of the liver, gallbladder, and intestine on bone scintigraphy. Clin Nucl Med 9 (1984) 440-443
80. Bhatnagar P., Chakraborti K.L., Sachdev P., et al. Serendipitous gallbladder uptake in a bone scan. Clin Nucl Med 30 (2005) 512-513
81. Ergun E.L., Kiratli P.O., Gunay E.C., et al. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature. Nucl Med Commun 27 (2006) 877-885
82. Conway J.J., Weiss S.C., Khentigan A., et al. Gallbladder and bowel localization of bone imaging radiopharmaceuticals. J Nucl Med 20 (1979) 622
83. Wallis J.W., Fisher S., and Wahl R.L. 99Tcm-MDP uptake by lymph nodes following tracer infiltration: Clinical and laboratory evaluation. Nucl Med Commun 8 (1987) 357-363
84. Chatterton B.E., Vannitamby M., and Cook D.J. Lymph node visualisation: An unusual artefact in the 99mTc-pyrophosphate bone scan. Eur J Nucl Med 5 (1980) 187-188
85. Dogan A.S., and Rezai K. Incidental lymph node visualization on bone scan due to subcutaneous infiltration of Tc-99m MDP. A potential for false positive interpretation. Clin Nucl Med 18 (1993) 208-209
86. Penney H.F., and Styles C.B. Fortuitous lymph node visualization after interstitial injection of Tc-99m-MDP. Clin Nucl Med 7 (1982) 84-85
87. Suga K., Ohono Y., Yoneshiro S., et al. A case of squamous cell carcinoma of urinary bladder with an ileo-vesical fistula detected on bone scintigraphy [in Japanese]. Kaku Igaku 29 (1992) 105-110
88. Mochizuki T., Kawai H., Nishimura T., et al. Uriposia after intravenous administration of technetium-99m HMDP. Clin Nucl Med 18 (1993) 435-436
89. Kosuda S., Katagiri S., Ka W.J., et al. Demonstration of the ascending colon on Tc-99m MDP skeletal imaging: Pitfall in bone scanning by a faith cure of drinking urine. Clin Nucl Med 25 (2000) 1040-1041
90. Tsai S.C., Kao C.H., Lin W.Y., et al. Intestinal accumulation of Tc 99m MDP on bone scan. Semin Nucl Med 29 (1999) 80-81
91. Wang Y.F., Cherng S.C., Cheng C.Y., et al. Colon visualization of bone scan: A special and interesting case. Clin Nucl Med 23 (1998) 723-724